BioTrove
BioTrove, Inc. offers two innovative technology platforms: OpenArray®, which
advances genomic research in a wide range of life science fields, including
agriculture, disease research, and public health, and RapidFire®, which
enables the acceleration of drug discovery and pipeline decisions. With 11
of the top 12 largest biopharmaceutical companies based on global sales as
clients, and partnerships with prestigious research and public health
centers around the world, BioTrove's products and services ensure that an
industry committed to accuracy and speed can meet business goals.
The OpenArray® Platform enables genomics researchers to generate SNP and real
time qPCR data in the hundreds of thousands of data points per day,
significantly increasing the number of samples analyzed while significantly
decreasing the time and cost required. The flexible format and nanoliter
scale of the OpenArray system allows for easy adjustment of sample and assay
numbers, achieving economical, high-throughput genomics. Life Technologies
globally markets the OpenArray SNP genotyping platform under the TaqMan®
OpenArray® SNP Genotyping brand. BioTrove is a licensee of Life Technologies
global patent rights related to the real-time thermal cyclers, microfluidics
and data analysis.
RapidFire® Mass Spectrometry (RF-MS) feeds samples directly to the mass
spectrometer at six to eight seconds per sample, eliminating the bottleneck
created by traditional mass spectrometry throughput. RF-MS is routinely
used in many applications including the high-throughput screening of
previously intractable drug targets, ADME assays and directed evolution
studies.
